ACS Chemical Neuroscience Molecule Spotlight on Potiga (Ezogabine)

作者：Hopkins Corey R^*

来源：ACS Chemical Neuroscience, 2012, 3(8): 632-632.

DOI：10.1021/cn3000789

• epilepsy
• seizures
• potassium channel opener
• Kv7

On June 10th, 2011, the U.S. Food and Drug Administration approved Potiga (ezogabine) as an add-on medication for the treatment of seizures in adults, and it is being developed by Valeant Pharmaceuticals.

• 出版日期2012-8